- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||domagrozumab|
|Search PubMed titles||domagrozumab|
|Search PubMed titles/abstracts||domagrozumab|
|Domagrozumab is a humanized monoclonal antibody targeting myostatin (MSTN), being investigated for potential therapeutic action in muscle wasting diseases.
Peptide sequences and structural information for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with sequences claimed in patent US8992913 .